Brandinium

Trademark search for:

SANTHERA PHARMACEUTICALS

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2007-11-02 — Application filed
  • 2007-11-07 — Application filed
  • 2007-11-08 — Notice of design search code mailed
  • 2008-02-14 — Assigned to examiner
  • 2008-02-15 — Examiners amendment and/or priority action - completed
  • 2008-02-15 — Notification of examiner's amendment/priority action e-mailed
  • 2008-02-15 — Examiner's amendment/priority action e-mailed
  • 2008-02-15 — Assigned to lie
  • 2008-02-19 — Combined examiner's amendment/priority action entered
  • 2008-08-12 — Paper received
  • 2008-08-25 — Amendment from applicant entered
  • 2008-08-25 — Correspondence received in law office
  • 2008-08-29 — Approved for pub - principal register
  • 2008-09-02 — Law office publication review completed
  • 2008-09-12 — Withdrawn from pub - og review query
  • 2008-10-15 — Previous allowance count withdrawn
  • 2008-10-31 — Data modification completed
  • 2008-11-06 — Approved for pub - principal register
  • 2008-11-10 — Law office publication review completed
  • 2008-11-26 — Notice of publication
  • 2008-12-16 — Published for opposition
  • 2008-12-19 — Extension of time to oppose received
  • 2009-04-27 — Opposition instituted no. 999999
  • 2010-05-13 — Paper received
  • 2010-05-19 — Attorney/dom.rep.revoked and/or appointed
  • 2010-05-19 — Teas revoke/app/change addr of atty/dom rep received
  • 2010-09-17 — Paper received
  • 2010-09-17 — Ttab release case to trademarks
  • 2010-09-17 — Opposition dismissed no. 999999
  • 2010-09-17 — Opposition terminated no. 999999
  • 2010-11-02 — Noa e-mailed - sou required from applicant
  • 2011-04-12 — Sou teas extension received
  • 2011-04-12 — Sou extension 1 filed
  • 2011-04-12 — Sou extension 1 granted
  • 2011-04-14 — Notice of approval of extension request e-mailed
  • 2011-10-31 — Sou teas extension received
  • 2011-10-31 — Sou extension 2 filed
  • 2011-11-01 — Case assigned to intent to use paralegal
  • 2011-11-02 — Sou extension 2 granted
  • 2011-11-03 — Notice of approval of extension request e-mailed
  • 2012-04-25 — Sou teas extension received
  • 2012-04-25 — Sou extension 3 filed
  • 2012-05-02 — Sou extension 3 granted
  • 2012-05-03 — Notice of approval of extension request e-mailed
  • 2012-10-25 — Sou teas extension received
  • 2012-10-25 — Sou extension 4 filed
  • 2012-10-30 — Sou extension 4 granted
  • 2012-10-31 — Notice of approval of extension request e-mailed
  • 2013-04-29 — Sou teas extension received
  • 2013-04-29 — Sou extension 5 filed
  • 2013-05-24 — Case assigned to intent to use paralegal
  • 2013-05-24 — Sou extension 5 granted
  • 2013-05-25 — Notice of approval of extension request e-mailed
  • 2013-09-09 — Assigned to examiner
  • 2013-12-09 — Application abandoned
  • 2013-12-09 — Application abandoned
  • 2013-12-09 — Final status recorded

Owner Information

Santhera Pharmaceuticals Holding AG
Liestal CH
Santhera Pharmaceuticals Holding AG
Liestal CH

Correspondent

PATRICK CONCANNON EDWARDS ANDELL PALMER & DODGE LLP
111 HUNTINGTON AVENUE
BOSTON, MA 02199
UNITED STATES

Filing Details

Filing Date:
2007-11-02
Status Date:
2013-12-09
Filing Year:
2007

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.